Stocks · KRX · Healthcare · South Korea
207940.KS — Samsung Biologics Co
Samsung Biologics Co (207940.KS) is a healthcare stock listed on KRX (South Korea). At the close of September 29, 2026 it traded at 1,385,000 (-1.07% on the day), -6.8% over one month, -4.3% over three months, -13.2% over twelve months. The InvestMuse composite score is -45 on a −100 to +100 scale, a bearish read that ranks #1102 of about 1,221 assets. The strongest of its nine dimensions are Chart patterns and zones (+15) and Technical indicators (+6); the weakest is Regime (hidden Markov model) (-60). Its volatility regime from the hidden Markov model is Cool.
The facts
| Last close | 1,385,000 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -1.07% / -6.8% / -4.3% / -13.2% |
| 52-week range | 1,243,000 – 1,965,000 |
| Composite score | -45 / 100 · bearish view · rank #1102 |
| Volatility regime (HMM) | Cool |
| Resistance levels | 657,350, 1,100,450, 1,291,800 |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-60
- Technical indicators+6
- Trend-50
- Support / resistance0
- Fundamentals0
- Sector edge0
- News sentiment0
- Momentum-9
- Chart patterns and zones+15
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.